Factor VIII circulates as a heterodimer composed of heavy (A1A2B domains) and light (A3C1C2 domains) chains, whereas the contiguous A1A2 domains are separate subunits in the active cofactor, factor VIIIa. Whereas the A1 subunit maintains a stable interaction with the A3C1C2 subunit, the A2 subunit is weakly associated in factor VIIIa and its dissociation accounts for the labile activity of the cofactor. In examining the ceruloplasmin-based factor VIII A domain model, potential hydrogen bonding based upon spatial separations of <2.8 Ă
were found between side chains of 14 A2 domain residues and 7 and 9 residues in the A1 and A3 domains, respectively. These residues were individually replaced with Ala, except Tyr residues were replaced with Phe, and proteins stably expressed to examine the contribution of each residue to protein stability. Factor VIII stability at 55°C and factor VIIIa activity were monitored using factor Xa generation assays. Fourteen of 30 factor VIII mutants showed >2-fold increases in either or both decay rates compared with wild type; whereas, 7 mutants showed >2-fold increased rates in factor VIIIa decay compared with factor VIII decay. These results suggested that multiple residues at the A1-A2 and A2-A3 domain interfaces contribute to stabilizing the protein. Furthermore, these data discriminate residues that stabilize interactions in the procofactor from those in the cofactor, where hydrogen bonding in the latter appears to contribute more significantly to stability. This observation is consistent with an altered conformation involving new inter-subunit interactions involving A2 domain following procofactor activation.Factor VIII, a plasma protein that participates in the blood coagulation cascade, is decreased or defective in individuals with hemophilia A. Factor VIII circulates as a non-covalent, metal ion-dependent heterodimer consisting of a heavy chain comprised of A1(a1)A2(a2)B 2 domains and a light chain comprised of (a3)A3C1C2 domains (see Ref. 1 for review). The factor VIII procofactor is activated by limited proteolysis catalyzed by thrombin or factor Xa to yield the cofactor, factor VIIIa, following cleavages at the a1A2, a2B, and a3A3 junctions. Thus, factor VIIIa is a heterotrimer of subunits designated A1, A2, and A3C1C2. Factor VIIIa functions as a cofactor for the serine protease factor IXa in the membrane-dependent conversion of zymogen factor X to the serine protease, factor Xa (see Ref. 1 for review). The role of the cofactor in the intrinsic factor Xase complex is to increase the catalytic efficiency of this reaction by several orders of magnitude. Factor Xase is self-dampening as a result of instability in the factor VIIIa cofactor due to weak electrostatic interactions between the A2 subunit and the A1/A3C1C2 dimer (2, 3). Limited information is available regarding the association of the A2 subunit in factor VIIIa. Fluorescence energy transfer results (4) and activity assays following swapping the human A1 domain for the porcine homolog (5) suggest that interactions o...